[go: up one dir, main page]

Bahouth et al., 1984 - Google Patents

Specific binding of a 125I-labeled substance P analog to rat submaxillary gland.

Bahouth et al., 1984

Document ID
2001457513403417393
Author
Bahouth S
Stewart J
Musacchio J
Publication year
Publication venue
The Journal of pharmacology and experimental therapeutics

External Links

Snippet

The substance P (SP) analog [tyrosine1, norleucine11]-substance P [(Tyr1, Nle11]-SP) was iodinated by the chloramine-T method to yield the mono iodinated derivative; both peptides were biologically active on the guinea-pig ileum SP receptor. Saturable, reversible binding …
Continue reading at jpet.aspetjournals.org (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

Similar Documents

Publication Publication Date Title
Nissenson et al. Synthetic peptides comprising the amino-terminal sequence of a parathyroid hormone-like protein from human malignancies. Binding to parathyroid hormone receptors and activation of adenylate cyclase in bone cells and kidney.
EP0917537B1 (en) Novel parathyroid hormone-related peptide analogs
JP4347566B2 (en) Modulation of SMR1-NEP interaction in diseases of the central nervous system that cause mental disorders
Abou-Samra et al. Non-Homologous Sequences of Parathyroid Hormone and the Parathyroid Hormone Related Peptide Bind to a CommonReceptor on ROS 17/2.8 Cells
EP1007566B1 (en) Therapeutic use of the smr1 protein and active derivatives thereof
HU219336B (en) Process for producing peptide derivatives and pharmaceutical compositions comprising such compounds and diagnostic unit containing such compounds
JP4871128B2 (en) A conformationally constrained parathyroid hormone (PTH) analog
Larsen et al. Binding of a iodinated substance P analog to a NK-1 receptor on isolated cell membranes from rat anterior pituitary
Bahouth et al. Specific binding of a 125I-labeled substance P analog to rat submaxillary gland.
US7238775B2 (en) Receptor(SSTR4)-selective somatostatin analogs
EP0029300A1 (en) Polypeptides, antisera containing them and methods of their use
Clark et al. A study of the cerebral cortex cholecystokinin receptor using two radiolabelled probes: evidence for a common CCK 8 and CCK 4 cholecystokinin receptor binding site
US7479480B2 (en) Peptides that promote lipid efflux
Gautvik et al. Peripheral metabolism of parathyroid hormone in patients with primary hyperparathyroidism as judged by immunological and biological studies
US6465613B1 (en) Hydrophilic somatostatin analogs
CA2163996A1 (en) Thrombin receptor radioligands and assays for identifying thrombin receptor antagonists
Mathur et al. Morphine like activity of some new Met-enkephalin analogues
Carlberg et al. [125I][d-Tyr25, Nle28, 31] CCK-(25–33): a convenient new aminopeptidase resistant cholecystokinin analogue for radioligand binding and autoradiography
WO2007048100A2 (en) Angio-inhibitory peptides derived from human timp-2
BAHOUTH Characterization of the substance P receptor on the rat submaxillary gland
Bisello et al. Development of a photoreactive parathyroid hormone antagonist to probe antagonist–receptor bimolecular interaction
Schvartz Molecular mechanisms of GnRH-induced desensitization and receptor regulation in pituitary cells